Market Tracker

04/17 6:05pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

3.46
Data as of Apr 17
 +0.04 / +1.17%
Today’s Change
2.62
Today|||52-Week Range
6.00
+2.98%
Year-to-Date
No recent news for Avanir Pharmaceuticals Inc.

Today’s Trading

Previous close3.42
Today’s open3.40
Day’s range3.34 - 3.63
Volume1,753,542
Average volume (3 months)2,266,048
Market cap$552.8M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+45.28%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales7.99
Price/Book29.88

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc+1.25+6.50%
RVNCRevance Therapeutics...+1.39+5.17%
ITCIITI Inc+0.43+2.74%
ARRYArray Biopharma Inc-0.05-1.30%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 12, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts